African Regulatory Harmonization Efforts Begin To Bear Fruit
Executive Summary
Moves towards greater harmonization of drug regulatory practices in Africa have gathered pace this year as a result of the adoption of legislation on the regulation of medical products and the growing adoption of harmonized requirements for drug approvals at regional level.
You may also be interested in...
New Manufacturing Technologies And Regulatory Convergence Expected To Improve Access In Developing Countries
The key to increasing access to biopharmaceuticals and vaccines in developing countries and to break affordability barriers is through advanced manufacturing platforms and regulatory partnerships such as AVAREF and through WHO's standards setting activities. Yet doubts about the continuing viability of the CPP in promoting access were expressed at recent industry meeting.
Transparency, IP Issues Dominate Discussion On WHO's Roadmap To Improve Drug Access
Advocacy groups want the WHO's proposed roadmap on improving access to medicines to include stronger language on transparency of R&D costs, prices and revenues. The pharmaceutical industry, however, believes any forward-looking solution should rest upon strong IP protection.
WHO Launches Twin-Track Procedure To Speed Access To Health Products
A procedure used to accelerate the approval of COVID-19 products during the pandemic is to be applied to all medicines using “synchronized and parallel, but otherwise entirely independent, processes,” the World Health Organization says.